1. Clinical Overview
Vinpocetine is a semi-synthetic derivative of the alkaloid vincamine, obtained from the leaves of the Lesser Periwinkle plant (Vinca minor). It is a cerebral vasodilator and neuroprotective agent primarily used for cognitive enhancement and cerebrovascular disorders. It improves cerebral metabolism by enhancing cerebral blood flow and oxygen utilization, and exhibits antioxidant, anti-inflammatory, and anti-platelet effects. In India, it is widely prescribed for symptoms related to cerebral insufficiency.
| Onset | Duration | Bioavailability |
|---|---|---|
| Approximately 1 hour after oral administration. | Approximately 6 to 8 hours. | Approximately 60-70% following oral administration. |
2. Mechanism of Action
Vinpocetine's primary mechanism involves selective inhibition of calcium-calmodulin-dependent phosphodiesterase type 1 (PDE1), leading to increased intracellular cyclic AMP (cAMP) and cyclic GMP (cGMP) levels. This results in vasodilation of cerebral blood vessels, improved cerebral blood flow, and enhanced neuronal metabolism. It also inhibits voltage-gated sodium channels, reducing neuronal excitotoxicity. It enhances cerebral glucose and oxygen uptake and utilization. Furthermore, it exhibits antioxidant properties by scavenging hydroxyl radicals and inhibiting lipid peroxidation, and has mild antiplatelet effects.
3. Indications & Uses
- Symptomatic treatment of cognitive disorders associated with cerebral insufficiency (e.g., memory deficits, concentration difficulties, dizziness)
- Adjuvant therapy in cerebrovascular accidents (post-stroke recovery)
- Vascular origin tinnitus and vertigo
4. Dosage & Administration
Adult Dosage: 5mg to 10mg, three times daily. Typical starting dose is 5mg TDS. Maximum daily dose is 30mg.
Administration: Administer orally with or after food to minimize potential gastric discomfort. Tablet should be swallowed whole with a glass of water. Do not crush or chew. Regular intervals (e.g., every 8 hours) are recommended for consistent effect.
5. Side Effects
Common side effects may include:
- Transient hypotension
- Dizziness
- Headache
- Facial flushing
- Gastrointestinal discomfort (nausea, dyspepsia, dry mouth)
- Sleep disturbances (insomnia or drowsiness)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Warfarin, Acenocoumarol | Increased risk of bleeding due to additive antiplatelet effect of vinpocetine. Monitor INR closely. | Major |
| Clopidogrel, Aspirin, NSAIDs (e.g., Ibuprofen) | Increased risk of gastrointestinal bleeding and other hemorrhagic events. | Moderate |
| Antihypertensives (e.g., Amlodipine, Losartan) | Additive hypotensive effect. May cause dizziness and postural hypotension. | Moderate |
| Central Nervous System Depressants (e.g., Alprazolam, Clonazepam) | Potential additive sedative effect. May impair alertness. | Moderate |
| Monoamine Oxidase Inhibitors (MAOIs) | Theoretical risk of hypertensive crisis; avoid combination. | Major |
7. Patient Counselling
- DO take the tablet exactly as prescribed by your doctor, usually 3 times a day.
- DO take it with food if you experience stomach upset.
- DO inform all your doctors and dentists that you are taking vinpocetine, especially before any surgery.
- DO report any signs of unusual bleeding (nosebleeds, bleeding gums, black stools) or severe dizziness to your doctor immediately.
- DONT stop taking the medicine suddenly without consulting your doctor.
- DONT crush or chew the tablet.
- DONT take a double dose to make up for a missed one. Skip the missed dose and take the next one at the regular time.
8. Toxicology & Storage
Overdose: Symptoms may include severe hypotension, bradycardia, marked dizziness, syncope, nausea, vomiting, and flushing. CNS depression or agitation may occur.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.